Someone online sparked my interest in recent TEVA buyouts. I wanted to share my findings so others could see the potential here with OWCP. Keep in mind, I’m not suggesting in any way that I’m aware of TEVA actively trying to acquire OWCP as of this writing. I’m simply pointing out it’s part of ‘big business’ now days.
UPDATE ON MARCH 8, 2017: Discovered by ‘Rhinegold’, a Dun & Bradstreet document (mid-way on Page 3) was found online that reveals in July 2015 — “Further to the info that subject approached One World Cannabis in order to start negotiations for the purchase of patents”
May 2nd, 2011 — “Teva to Acquire Cephalon in $6.8 Billion Transaction” (Source)
Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion.
July 3rd, 2014 — “Teva to Acquire Labrys Biologics, Inc.” (Source)
Teva will acquire Labrys for $200 million in upfront payment in cash at closing as well as up to $625 million in contingent payments upon achievement of certain pre-launch milestones.
July 27th, 2015 — “Teva to Acquire Allergan Generics for $40.5 Billion” (Source)
Allergan will receive $33.75 billion in cash and shares of Teva valued today at $6.75 billion, representing an estimated under 10% ownership stake in Teva, with the number of Teva shares determined based on Teva’s volume weighted average trading prices during the 15 days prior to the announcement and five days following the announcement.
August 3rd, 2016 — “Teva Announces Acquisition of Anda Inc. for $500 million” (Source)
Teva today announced that it has entered into a definitive agreement to purchase Allergan’s Anda Inc., the 4th largest distributor of generic pharmaceuticals in the U.S. for $500 million.
These are just the ‘bigger’ transactions. There were a few others for $100M – $250M here and there. But, you get the point. Teva, who is located “just down the street” from OWCP in Israel, has money and likes to acquire other promising pharmaceutical companies for BIG BUCKS.
With many pointing out OWCP being fully capable of surpassing GWPH’s market value within the next 12 – 18 months — it all goes to show OWCP should quickly rise to a multi-Billion dollar Market Value in due time. Quite frankly, they could rise to these levels by end of 2017.